Adage Capital Partners’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.82M | Hold |
421,322
| – | – | ﹤0.01% | 767 |
|
|
2025
Q1 | $1.58M | Sell |
421,322
-1
| -0% | -$4 | ﹤0.01% | 773 |
|
|
2024
Q4 | $4.27M | Buy |
421,323
+133,334
| +46% | +$1.35M | 0.01% | 730 |
|
|
2024
Q3 | $3.59M | Hold |
287,989
| – | – | 0.01% | 744 |
|
|
2024
Q2 | $3.75M | Buy |
287,989
+54,656
| +23% | +$711K | 0.01% | 738 |
|
|
2024
Q1 | $5.29M | Buy |
233,333
+122,446
| +110% | +$2.77M | 0.01% | 689 |
|
|
2023
Q4 | $1.44M | Buy |
+110,887
| New | +$1.44M | ﹤0.01% | 752 |
|
|
2023
Q1 | – | Sell |
-51,381
| Closed | -$2.62M | – | 956 |
|
|
2022
Q4 | $2.62M | Buy |
+51,381
| New | +$2.62M | 0.01% | 798 |
|
|
2021
Q2 | – | Sell |
-89,987
| Closed | -$14.2M | – | 1039 |
|
|
2021
Q1 | $14.2M | Sell |
89,987
-74,346
| -45% | -$11.7M | 0.03% | 571 |
|
|
2020
Q4 | $38.2M | Sell |
164,333
-49,862
| -23% | -$11.6M | 0.08% | 262 |
|
|
2020
Q3 | $46.9M | Sell |
214,195
-2,388
| -1% | -$523K | 0.12% | 185 |
|
|
2020
Q2 | $61.5M | Sell |
216,583
-31,652
| -13% | -$8.99M | 0.16% | 150 |
|
|
2020
Q1 | $71.5M | Sell |
248,235
-4,232
| -2% | -$1.22M | 0.21% | 116 |
|
|
2019
Q4 | $72.6M | Buy |
252,467
+139,134
| +123% | +$40M | 0.18% | 146 |
|
|
2019
Q3 | $16.4M | Buy |
+113,333
| New | +$16.4M | 0.04% | 412 |
|